Ropinirole and pramipexole: comparative adverse event profiles Parkinson's disease patients

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2003年 / 951卷 / 1期
关键词：
Public Health; Adverse Event; Placebo; High Risk; Dopamine;
D O I：
10.2165/00128415-200309510-00013
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：5 / 5
相关论文
共 50 条
  • [1] Pramipexole and ropinirole for Parkinson's disease
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 1997, 39 (1014): : 109 - 110
  • [2] Pramipexole, ropinirole, and mania in Parkinson's disease
    Singh, A
    Althoff, R
    Martineau, RJ
    Jacobson, J
    AMERICAN JOURNAL OF PSYCHIATRY, 2005, 162 (04): : 814 - 815
  • [3] Comparison of the risk of adverse events with pramipexole and ropinirole in patients with Parkinson's disease - A meta-analysis
    Etminan, M
    Gill, S
    Samii, A
    DRUG SAFETY, 2003, 26 (06) : 439 - 444
  • [4] Clinical pharmacokinetics of pramipexole, ropinirole and rotigotine in patients with Parkinson's disease
    Contin, Manuela
    Lopane, Giovanna
    Mohamed, Susan
    Calandra-Buonaura, Giovanna
    Capellari, Sabina
    De Massis, Patrizia
    Nassetti, Stefania
    Perrone, Alessandro
    Riva, Roberto
    Sambati, Luisa
    Scaglione, Cesa
    Cortelli, Pietro
    PARKINSONISM & RELATED DISORDERS, 2019, 61 : 111 - 117
  • [5] COMPARISON OF PRAMIPEXOLE VERSUS ROPINIROLE IN THE TREATMENT OF PARKINSON'S DISEASE
    Gencler, Onur Serdar
    Oztekin, Nese
    Oztekin, Mehmet Fevzi
    IDEGGYOGYASZATI SZEMLE-CLINICAL NEUROSCIENCE, 2022, 75 (1-2): : 37 - 47
  • [6] Ropinirole after pramipexole failure in advanced Parkinson's disease
    Weiner, WJ
    Minagar, A
    Shulman, LM
    ANNALS OF NEUROLOGY, 1998, 44 (03) : 502 - 502
  • [7] Comparison of the Risk of Adverse Events with Pramipexole and Ropinirole in Patients with Parkinson’s DiseaseA Meta-Analysis
    Mahyar Etminan
    Sudeep Gill
    Ali Samii
    Drug Safety, 2003, 26 : 439 - 444
  • [8] Ropinirole versus pramipexole as adjunctive therapy to levodopa in Parkinson's disease
    Barbato, L
    Cattaneo, C
    Monge, A
    Nordera, G
    MOVEMENT DISORDERS, 2002, 17 : S49 - S49
  • [9] Indirect Comparisons of Adverse Events and Dropout Rates in Early Parkinson's Disease Trials of Pramipexole, Ropinirole, and Rasagiline
    Zagmutt, Francisco J.
    Tarrants, Marcy L.
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2012, 122 (07) : 345 - 353
  • [10] Discontinuation of ropinirole and pramipexole in patients with Parkinson's disease: clinical practice versus clinical trials
    Arbouw, Maurits E. L.
    Movig, Kris L. L.
    Guchelaar, Henk-Jan
    Poels, Petra J. E.
    van Vugt, Jeroen P. P.
    Neef, Cees
    Egberts, Toine C. G.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 64 (10) : 1021 - 1026
12345